The Outcome of COVID-19 in Pediatric-Onset Multiple Sclerosis Patients.

Oncel, Ibrahim; Alici, Nurettin; Solmaz, Ismail; Oge, Dogan Dinc; Ozsurekci, Yasemin; Anlar, Banu

Oncel, Ibrahim; Alici, Nurettin; Solmaz, Ismail; Oge, Dogan Dinc; Ozsurekci, Yasemin; Anlar, Banu.

Afiliación

Oncel I; Department of Pediatric Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey. Electronic address: dribrahimoncel@gmail.com.
Alici N; Department of Pediatric Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Solmaz I; Department of Pediatric Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Oge DD; Department of Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Ozsurekci Y; Department of Pediatric Infectious Disease, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Anlar B; Department of Pediatric Neurology, Hacettepe University Faculty of Medicine, Ankara, Turkey.

Pediatr Neurol ; 134: 7-10, 2022 09.

Article en En | MEDLINE | ID: mdl-35772229

Asunto(s)

COVID-19; Esclerosis Múltiple; Adulto; COVID-19/complicaciones; Niño; Estudios Transversales; Humanos; Esclerosis Múltiple/complicaciones; Esclerosis Múltiple/tratamiento farmacológico; Esclerosis Múltiple/epidemiología; Pandemias; SARS-CoV-2

Palabras clave

COVID-19; Disease-modifying therapy; Pediatric-onset multiple sclerosis; Severity

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: COVID-19 / Esclerosis Múltiple Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies Límite: Adult / Child / Humans Idioma: En Revista: Pediatr Neurol Asunto de la revista: NEUROLOGIA / PEDIATRIA Año: 2022 Tipo del documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google